- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01189149
Intravenous Fluids Versus Naso/Orogastric-tube Feeding in Hospitalized Infants With Bronchiolitis
February 5, 2013 updated by: Bnai Zion Medical Center
Intravenous Fluids vs. Naso/Orogastric-tube Feeding in Hospitalized Infants With Acute Viral Bronchiolitis: a Randomized, Controlled, Prospective Clinical Trial
Oro- or nasogastric tube feeding is safe and may be more physiologic than intravenous (IV) fluids in hospitalized infants with acute viral bronchiolitis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
35
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Haifa, Israel
- Pediatric department
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 day to 6 months (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Infants with bronchiolitis < 6 months who need to be hospitalized and are not able to eat per os.
Exclusion Criteria:
- Infants with severe bronchiolitis not allowed to get any gastric feeds or those that their parents will not sign an informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: IV fluids
Infants will get IV fluids whem indicated until able to tolerate full oral feedings
|
Infants will be allocated to IV fluids
|
|
Experimental: Oro/naso gastric tube feeding
Infants will get oro/naso gastric tube feeding whem indicated until able to tolerate full oral feedings
|
Infants will be allocated to naso/oro gastric tube feedings
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical outcomes
Time Frame: 3 winters
|
Will compare clinical outcomes between the groups: Length of stay, need for oxygen, time to full feeds etc.
|
3 winters
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Possible side effects of each method (IV vs. Oro/nasogastric feedings)
Time Frame: 3 winters
|
Local or systemic signs of infection, "para"infusion, discomfort while inserting the IV, electrolyte abnormalitis (as part of routine care) vs. aspiration, discomfort with naso/oro gastric tube.
|
3 winters
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2008
Primary Completion (Actual)
March 1, 2012
Study Completion (Actual)
March 1, 2012
Study Registration Dates
First Submitted
August 23, 2010
First Submitted That Met QC Criteria
August 25, 2010
First Posted (Estimate)
August 26, 2010
Study Record Updates
Last Update Posted (Estimate)
February 6, 2013
Last Update Submitted That Met QC Criteria
February 5, 2013
Last Verified
December 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 115/08
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Viral Bronchiolitis
-
Guy's and St Thomas' NHS Foundation TrustCompletedAcute Viral BronchiolitisUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisCompletedAcute Viral BronchiolitisFrance
-
Ministry of Health, SpainCompleted
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinCompletedSevere Viral BronchiolitisFrance
-
Hospices Civils de LyonCompleted
-
Groupe Hospitalier du HavreCompletedAcute Viral BronchiolitisFrance
-
Laval UniversityCanadian Institutes of Health Research (CIHR); Centre de Recheche du Centre...WithdrawnAcute Viral Bronchiolitis.Canada
-
Pontificia Universidade Católica do Rio Grande...CompletedAcute Viral Bronchiolitis
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Hillel Yaffe Medical CenterCompletedReflexology | Bronchiolitis; ChemicalIsrael
Clinical Trials on IV fluids
-
Hospital Departamental de VillavicencioNot yet recruitingTrauma and Emergency Care | Shock,Hemorrhagic | Intravenous Fluid TherapyColombia
-
Stanford UniversityCompleted
-
University of CalgaryMcGill University; University of Ottawa; Queen's University; Halton Health (Oakville) and other collaboratorsRecruiting
-
Samsung Medical CenterCompleted
-
Austin HealthCompletedCardiac SurgeryAustralia
-
The Hospital for Sick ChildrenCompleted
-
Federal University of Minas GeraisCompletedThirst | Postoperative Nausea | Postoperative Vomiting | Hunger | Fluid Electrolyte Disorders | Renal Function Abnormal
-
Massachusetts General HospitalMount Auburn Hospital; Pro EMSWithdrawn
-
Mt. Sinai Medical Center, MiamiFlorida Heart Research InstituteCompleted
-
University of CalgaryMedical University of South Carolina; University of Colorado, Denver; The Hospital... and other collaboratorsRecruitingHemolytic-Uremic Syndrome | Shiga Toxin-Producing Escherichia Coli (E. Coli) InfectionUnited States, Canada